期刊文献+

中药有效成分抑制氧化应激诱导的神经细胞凋亡机制研究进展 被引量:7

Research advances in the mechanisms of active components in Chinese materia medica against oxidative stress-induced neuronal apoptosis
下载PDF
导出
摘要 氧化应激诱导的神经细胞凋亡,在神经退行性疾病的发生及发展过程中发挥重要作用,其调控途径主要包括NF-κB通路、p53通路、MAPK通路、PI3K/Akt通路、Nrf2通路等信号通路。大量文献报道,中药有效成分具有显著抑制氧化应激诱导的神经细胞凋亡的生物活性。本文综述近5年来中药有效成分抑制氧化应激诱导的神经细胞凋亡的相关机制研究进展,以期为阐释中药有效成分防治神经退行性疾病的作用机制,更有效地防治神经退行性疾病提供参考依据和线索。 Oxidative stress-induced neuronal apoptosis plays a vital role in the development of neurodegenerative disorders;while at present its regulation pathways mainly include the NF-κB pathway;p53 pathway;MAPK path-way;PI3 K/Akt pathway;Nrf2 pathway;as well as other signaling pathways.Research findings suggest that the active components in Chinese materia medica exert significant biological activities in the treatment of oxidative stress-induced neuronal apoptosis.In the present paper;we review the recent research advances on the relative mechanisms of active components in Chinese materia medica against oxidative stress-induced neuronal apoptosis;so as to provide some references or clues for the clarification of possible mechanisms of active components in Chinese materia medica and the treatment of related neurodegenerative diseases.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2015年第5期532-540,共9页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.81274004)~~
关键词 中药有效成分 神经细胞 氧化应激 凋亡 神经退行性疾病 active components in Chinese materia medica neuron oxidative stress apoptosis neurodegenerative disease
  • 相关文献

参考文献2

二级参考文献79

  • 1Smith AG, Singleton JR. Diabetic neuropathy. Continuum (Minneap Minn) 2012; 18: 60-84.
  • 2Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003; 60:108-11.
  • 3Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001; 24: 1448-53.
  • 4Vincent AM, Callaghan BC, Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 2011; 7: 573-83.
  • 5Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008; 120: 1-34.
  • 6Vincent AM, Edwards JL, Sadidi M, Feldman EL. The antioxidant response as a drug target in diabetic neuropathy. Curr Drug Targets 2008; 9: 94-100.
  • 7Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002; 288: 2579-88.
  • 8Negi G, Kumar A, Joshi RP, Sharma SS. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem Biophys Res Commun 2011; 408: 1-5.
  • 9Negi G, Kumar A, Sharma SS. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-kappaB and Nrf2 cascades. J Pineal Res 2011; 50:124-31.
  • 10Kumar A, Sharma SS. NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem Biophys Res Commun 2010; 394: 360-5.

共引文献27

同被引文献128

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部